Case Study: Severe Finger Infection in Diabetic Patient Treated with CDS Protocol F and C with Honey

Testimonial

This is a personal testimonial from a patient who suffered a severe finger infection that was resistant to multiple treatments, including penicillin. The patient had recently been diagnosed with diabetes type "B" and hypertension, conditions that complicated the infection and made it increasingly difficult to treat.

Patient Background

The patient had a serious infection in one of their fingers that worsened over time despite multiple treatment attempts. The infection was so severe that the family, particularly the patient's eldest daughter, insisted on seeking emergency medical attention.

The initial diagnosis at the Emergency Room was minimal, but the severity of the infection raised concerns about potential amputation of the finger, hand, or even arm. The patient was referred to a Level 1 Hospital, and after radiographic evaluation, was transferred to a Level 2 Hospital with specialists in Reconstructive Surgery.

The specialists indicated that the patient would require hospitalization for a period of two to three months, along with a series of studies to determine the type of bacteria and develop an appropriate treatment plan.

Medical Treatment Failure

The patient requested a "Second Opinion" and refused hospitalization. The patient was discharged against medical advice.

Penicillin Resistance: The infection had been treated with multiple courses of penicillin, but none of these treatments were effective. The patient reports that with penicillin treatments, the infection never improved and actually worsened in the intervals between treatments. This suggests the bacteria responsible for the infection was resistant to penicillin.

The inability of conventional antibiotic treatment (penicillin) to control the infection highlights a growing global health concern: antibiotic resistance. When bacteria develop resistance to commonly used antibiotics, infections become progressively more difficult to treat and can lead to severe complications including tissue necrosis, gangrene, and amputation.

Treatment Decision

The patient decided to pursue an alternative treatment approach, trusting in chlorine dioxide (CDS) protocol. The patient states: "I only wanted to buy time and treat myself with CDS, which I truly believe in."

The patient initiated the CDS protocol immediately, using:

Protocol F 20: 20 drops of Protocol F
Protocol C 20: 20 drops of Protocol C
The remainder of the day was dedicated to the CDS protocol

Treatment Protocol Applied

The patient administered the CDS treatment using the following method:

Atomizer Application: CDS was applied to the affected finger using an atomizer (spray) without dilution. This direct application ensured maximum concentration of chlorine dioxide at the site of infection
Honey Application: Following the CDS atomizer application, honey was applied to the finger. Honey has well-documented antimicrobial properties and has been used traditionally for wound healing. The combination of CDS and honey was intended to create a synergistic effect - CDS for broad-spectrum antimicrobial action and honey for wound healing and tissue repair
Bandaging: The finger was bandaged with gauze after the CDS and honey application to protect the wound and maintain a clean environment for healing
Consistent Application: The treatment was applied consistently, with the patient reporting the process ongoing

Results

The patient reports that the CDS treatment with honey showed positive results. The infection, which had been resistant to penicillin and was progressing toward potential amputation, began to improve with the CDS protocol.

The patient notes that the process is not yet complete, but the improvement observed so far is significant given the severity of the infection and its resistance to conventional medical treatment.

Why This Case Matters

This case is particularly significant for several reasons:

Antibiotic Resistance: The infection was resistant to penicillin despite multiple treatment courses. This case demonstrates a real-world example of antibiotic-resistant infection, a growing global health crisis
Diabetic Complication: The patient had newly diagnosed diabetes, which is known to impair wound healing and increase susceptibility to infections. Diabetic foot and hand infections can be particularly challenging and often require aggressive treatment
Avoided Amputation: Without the CDS treatment, the patient faced potential amputation of the finger, hand, or even arm. The successful treatment with CDS and honey may have prevented this devastating outcome
Patient Self-Advocacy: The patient refused hospitalization and sought an alternative treatment, demonstrating the importance of patient autonomy and the pursuit of all available treatment options
Natural Treatment Efficacy: The combination of CDS (chlorine dioxide) with honey represents a natural treatment approach that achieved results where conventional medicine failed
Cost-Effectiveness: The CDS protocol is significantly less expensive than a 2-3 month hospitalization, multiple specialist consultations, radiographic studies, and potential surgical interventions including amputation

Timeline

Initial Infection: Patient develops severe finger infection
Diagnosis: Patient diagnosed with diabetes type "B" and hypertension
Emergency Room Visit: Family insists on medical attention; diagnosis of potential amputation
Hospital Referral: Patient referred to Level 1 Hospital, then Level 2 Hospital with Reconstructive Surgery specialists
Medical Recommendation: Specialists recommend 2-3 months hospitalization, studies to identify bacteria
Patient Discharge: Patient requests second opinion, refuses hospitalization, and is discharged
CDS Treatment Initiation: Patient begins Protocol F 20 + Protocol C 20, atomizer application without dilution, honey application, gauze bandaging
Ongoing: Treatment process continues with positive results noted

Source

Personal testimonial provided by the patient. Photographic documentation of the treatment process included. Date: 2026.